Scientists discover two brand new viruses in bats in China – and warn they could spill over to humans
Researchers have found two new viruses in the flying mammals that are closely related to the deadly Nipah and Hendra viruses – both of which are fatal to humans.
Experts have raised urgent concerns about the potential of these viruses to jump to local people.
And there is currently no medication or vaccine to treat either of them.
'These findings broaden our understanding of the bat kidney infectome, underscore critical zoonotic threats and highlight the need for comprehensive, full-spectrum microbial analyses of previously understudied organs to better assess spillover risks from bat populations,' the researchers said.
For their study, the team from the Yunnan Institute of Endemic Disease Control and Prevention analysed the kidneys of 142 bats from 10 species collected over four years.
Using advanced genetic sequencing they found 22 viruses – 20 of them never seen before.
Two of the most concerning were new henipaviruses, closely related to the Nipah and Hendra viruses.
These were found in fruit bats (Rousettus leschenaultia) living near orchards close to human villages in Yunnan.
Since henipaviruses can spread through urine, the study raises concerns about contaminated fruit and the risk of these viruses jumping to humans.
The team published their findings in the journal Plos Pathogens.
They wrote: 'By analysing the infectome of bat kidneys collected near village orchards and caves in Yunnan, we uncovered not only the diverse microbes bats carry, but also the first full-length genomes of novel bat-borne henipaviruses closely related to Hendra and Nipah viruses identified in China.'
They said their findings raise 'urgent concerns about the potential for these viruses to spill over into humans or livestock.'
Bats are natural reservoirs for a wide range of microorganisms, including some that have previously been transmitted to humans.
One theory is that the coronavirus could have originated in bats and then spilled over into people, triggering the global Covid pandemic.
However, others argue it came from a 'lab leak' or from other animals being sold at a wet market.
The animals have also been linked to Ebola and Middle East respiratory syndrome (MERS) outbreaks.
'Bat-borne viruses are transmitted to human either direct contact with bats or via so-called 'intermediate' hosts, often linked to the ingestion of food or water contaminated with bat saliva, faeces or urine,' the researchers added.
They warned: 'Nipah virus are lethal pathogens that cause severe disease in humans, including acute respiratory distress and encephalitis, with a mortality rate of 35-75 per cent.
'Similarly, Hendra virus has caused multiple fatal outbreaks in humans and horses, including the death of veterinarians.'
Separately, experts have warned that dozens of viruses – some of which have the potential to spill over into humans – have been detected mixing in animals at fur farms in China, sparking new fears of a fresh pandemic outbreak.
Since the Covid-19 pandemic, scientists have been warning that farming mammals such as minks for their fur could make it easier for new viruses to cross over from the wild and spark fresh outbreaks.
Virologist Edward Holmes, who has led research into Covid-19, told AFP he felt that the global fur farming industry 'is one most likely ways by which a new pandemic will start'.
'Personally, I think the fur farming industry globally should be closed down,' he added.
'I strongly believe that the wildlife trade was responsible for the emergence of SARS-CoV-2.
'And I think that the related fur farming trade could easily result in another pandemic virus.'
It might sound bat crazy, but these disease-riddled cave-dwelling creatures of the night might hold the key to curing CANCER
They have become much maligned due to their links to the Covid pandemic - but bats may hold the secret to curing cancer.
A new study found some species contain more than 50 unique genes that may make them immune to tumors - even though they live extraordinarily long lives.
Bats have mystified scientists for years due to their unique ability to live normally with viruses that kill or sicken most other mammals - and people.
Yet this ability to tolerate viruses put them at the center of questions about the origin of Covid, which is thought to have emerged in the animals.
Researchers hope that by developing a better understanding of their miracle immune systems, they can develop ways to prevent and treat cancer in people.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
an hour ago
- Reuters
Earthquake of magnitude 6.2 strikes Indonesia's Sulawesi, GFZ says
July 24 (Reuters) - A magnitude 6.2 earthquake struck Minahassa Peninsula, in Indonesia's Sulawesi region, on Thursday, the German Research Centre for Geosciences said. The quake was at a depth of 147 kilometers (91.96 miles), GFZ said.
Daily Mail
4 hours ago
- Daily Mail
Experts warn of another global epidemic as rare virus spreads to new areas
The World Health Organization has issued an urgent call for action as cases of chikungunya virus explode across the globe. The chikungunya virus is spread primarily by the Aedes mosquito species and nearly half a million people became infected between 2004 and 2005 - leading to a worldwide epidemic. Chikungunya infections are most common in Asia, Africa and South America though more recently cases have also emerged across Europe and the US. The virus can cause symptoms like fever, joint pain and life-threatening complications related to the heart and brain. The infection does not spread from person to person through bodily contact or saliva and can only be transmitted through a bite from an infected mosquito. Since there is no specific medical treatment for the chikungunya infections, experts are asking people to regularly use insect repellents and wear long-sleeve clothing to prevent mosquito bites this summer Diana Rojas Alvarez, a medical officer at the who said of the new cases: 'We are seeing history repeating itself,' referencing the 2004-2005 epidemic. The current surge began in early 2025, with major outbreaks in the Indian Ocean islands of La Reunion, Mayotte and Mauritius. According to the European Center for Disease Prevention and Control, there have been about 220,000 Chikungunya virus cases and 80 related deaths in 14 countries since the beginning of 2025. An estimated one-third of La Reunion's population - nearly 300,000 people - have already been infected, according to Rojas Alvarez. During the last epidemic, about 266,000 people were infected out of which 203 died on La Reunion. The virus has also spread to Madagascar, Somalia, Kenya and India and is making its way to Europe. There have been approximately 800 imported chikungunya cases in continental France since May 1, Rojas Alvarez said. Out of the 800 cases, 12 of the infected people had been bitten by local mosquitoes without having travelled to high-risk areas in several southern French regions. The chikungunya outbreak has occurred far earlier in the year than is typical, and this could indicate the mosquitoes that carry chikungunya are becoming increasingly at home in France thanks to climate change, officials warned. Two cases have also been reported in Italy this week and both people were infected within the country rather than abroad, according to the Foreign Office-backed Travel Health Pro. In June of this year, Australian vacationers were issued a warning AS The Cook Islands, a nation in the South Pacific, declared the most recent outbreak of the disease after 19 cases were recorded. Case counts have also been increasing in Samoa, Tonga, French Polynesia, Fiji and Kiribati. As of July 16, two dozen cases of chikungunya infections in the US that had been contracted while traveling to high-risk areas have been reported by the CDC. While it remains unclear where patients contracted the virus, the federal agency has issued an elevated risk of exposure notice for Brazil, Colombia, India, Mexico, Nigeria, Pakistan, Philippines and Thailand. Approximately 200 cases of the virus were reported in 2024 in the US. According to the CDC, chikungunya was rarely identified in American travelers before 2006. However between 2006– and 2013, nearly 30 people tested positive for the infection every year in the US. All were travelers visiting or returning to the US from affected areas in Asia, Africa, or the Indian Ocean. In 2014, 2,799 cases, out of which 12 were locally-acquired, were reported in various US states including Florida, Texas, Puerto Rico, and the Virgin Islands - marking the year as the highest ever. Though not fatal, chikungunya can cause a range of effects, which are primarily marked by a sudden onset of fever and severe joint pain, while other common symptoms include muscle pain, headache, nausea, fatigue and rashes. While the acute phase of the illness usually resolves within a week or two, the joint pain can persist for weeks, months or even years in some individuals. However, in some cases, infections can progress to severe dengue, which can cause potentially life-threatening complications such as internal bleeding and organ damage, and death. In extreme cases, eye, heart and neurological complications have also been reported in people suffering from a chikungunya infection. Newborns, adults aged 65 and older and people with certain health conditions are also at the risk of developing Type 2 diabetes, heart disease and high blood pressure due to an infection. While the virus cannot be transmitted directly from person to person, people can become infected with chikungunya when mosquitoes feed on another infected person and then bite them. If a pregnant woman is infected around the time of delivery, the baby can also be infected at birth, which often results in severe disease in the baby. While there is no medication to treat a chikungunya infection, its symptoms can be managed by taking acetaminophen for pain and drinking lots of fluids. In late 2023, the FDA also approved a vaccine for chikungunya for people over the age of 18 who are at increased risk of exposure to the virus called IXCHIQ.
The Independent
8 hours ago
- The Independent
Scientists create temporary tattoo that detects if your drink has been spiked
Scientists have created a temporary tattoo that can detect if a drink has been spiked with just a couple drops. The sticker, which is applied to the skin, can detect the presence of the drug Y-hydroxybutyrate (GHB) even in low concentrations within one second. Commonly used to spike drinks, the central nervous system depressant drug Rohypnol, known as roofies or GHB, has been liked with sexual assault. It causes drowsiness, slows down your breathing and reduces heart rate. These drugs are colourless, tasteless and induce a stupor in victims that is similar to severe alcohol intoxication – leaving people vulnerable to sexual assault. The prevalence of spiking is high with 11 per cent of UK adults report being spiked at any point in their lives, according to Drinkaware. It added that 9 per cent of men and 13 per cent of women have reported their drink being spiked. There are ways people can protect themselves from drink spiking, with specialised strips and cards that change colour when exposed to these drugs. But many of these drug testing kits are conspicuous or take minutes to report a result. In the study published in the journal ACS Sensors, researchers in South Korea set out to develop a rapid-acting test for GHB that's worn on the skin using a tattoo-like sticker. Gyeong-Ji Kim, Jai Eun An, Kyong-Cheol Ko, Oh Seok Kwon and colleagues created the stickers by placing a mould over the top of a thin plastic film decorated with tattoo-like designs. They poured a gel mixture into the mould which contained a chemical receptor that turns red when it detects GHB. The back of the sticker was then coated with a diluted glue solution, so it could stick to skin. Researchers tested the sticker's ability to detect small amounts of GHB in a variety of beverages: whiskey, vodka, beer, soju (a Korean alcoholic beverage) and coffee. The drug was detected within one second of coming into contact with the contaminated drinks. It even changed colour when it detected levels of the drug lower than what would induce serious physiological symptoms – 0.01 micrograms of GHB in 1 millilitre of beverage. The sticker is designed to be able to discreetly dip a finger into a drink, touch the drop to the sticker and see the result almost immediately. A positive result displays for up to 30 days after detection, which could be important if it's needed as a form of evidence of tampering. The researchers say that their sticker technology is inexpensive and easy to manufacture, and it could be commercially available soon.
